Newborn screening
- GP's role
- The newborn screening process
- Storage of newborn screening cards
- Figure 1: The newborn screening (NBS) process
- Newborn screening results
- Where no further testing is required
- Where further testing is required
- Policies governing conditions included in newborn screening
- Conditions tested for using newborn screening
- Cystic fibrosis
- Common clinical features
- Test
- Figure 2: Newborn screening for CF
- Treatment
- Implications for other family members
- Phenylketonuria
- Common clinical features
- Test
- Treatment
- Implications for other family members
- Galactosaemia
- Common clinical features
- Test
- Treatment
- Implications for other family members
- Primary congenital hypothyroidism
- Common clinical features
- Test
- Treatment
- Implications for other family members
- Other amino acidopathies
- Test
- Rare metabolic conditions
- Disorders of fatty acid oxidation
- Organic acidaemias/acidurias
- Rare metabolic conditions that are recommended in Australian newborn screening programmes
- Amino acidopathies
- Fatty acid oxidation disorders
- Organic acid disorders
- Bibliography
- Patient and family fact sheet
- Newborn screening